Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinoma
In the last decade, implications of human telomerase reverse transcriptase (hTERT), a component of ribonucleoprotein telomerase in aging, senescence, and stem cell are highly evident. Besides, the activation of hTERT is also being documented several cancer types including carcinoma. The awakening of...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-03-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317695951 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849710298537132032 |
|---|---|
| author | Ajay Kumar Pritish Nilednu Azad Kumar Nilesh Kumar Sharma |
| author_facet | Ajay Kumar Pritish Nilednu Azad Kumar Nilesh Kumar Sharma |
| author_sort | Ajay Kumar |
| collection | DOAJ |
| description | In the last decade, implications of human telomerase reverse transcriptase (hTERT), a component of ribonucleoprotein telomerase in aging, senescence, and stem cell are highly evident. Besides, the activation of hTERT is also being documented several cancer types including carcinoma. The awakening of telomerase during carcinoma initiation and development is being seen with different perspectives including genetic and epigenetic tools and events. In view of several tumor progenitors genes (also referred as epigenetic mediators), telomerase is placed as key enzyme to achieve the carcinoma phenotype and sustain during the progression. It is true that swaying of telomerase in carcinoma could be facilitated with dedicated set of epigenetic modulators and modifiers players. These epigenetic alterations are heritable, potentially reversible, and seen as the epigenetic signature of carcinoma. Several papers converge to suggest that DNA methylation, histone modification, and small non-coding RNAs are the widely appreciated epigenetic changes towards hTERT modulation. In this review, we summarize the contribution of epigenetic factors in the telomerase activation and discuss potential avenues to achieve therapeutic intervention in carcinoma. |
| format | Article |
| id | doaj-art-7a0d7cab4e694d85a982de4382758462 |
| institution | DOAJ |
| issn | 1423-0380 |
| language | English |
| publishDate | 2017-03-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Tumor Biology |
| spelling | doaj-art-7a0d7cab4e694d85a982de43827584622025-08-20T03:14:57ZengSAGE PublishingTumor Biology1423-03802017-03-013910.1177/1010428317695951Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinomaAjay KumarPritish NilednuAzad KumarNilesh Kumar SharmaIn the last decade, implications of human telomerase reverse transcriptase (hTERT), a component of ribonucleoprotein telomerase in aging, senescence, and stem cell are highly evident. Besides, the activation of hTERT is also being documented several cancer types including carcinoma. The awakening of telomerase during carcinoma initiation and development is being seen with different perspectives including genetic and epigenetic tools and events. In view of several tumor progenitors genes (also referred as epigenetic mediators), telomerase is placed as key enzyme to achieve the carcinoma phenotype and sustain during the progression. It is true that swaying of telomerase in carcinoma could be facilitated with dedicated set of epigenetic modulators and modifiers players. These epigenetic alterations are heritable, potentially reversible, and seen as the epigenetic signature of carcinoma. Several papers converge to suggest that DNA methylation, histone modification, and small non-coding RNAs are the widely appreciated epigenetic changes towards hTERT modulation. In this review, we summarize the contribution of epigenetic factors in the telomerase activation and discuss potential avenues to achieve therapeutic intervention in carcinoma.https://doi.org/10.1177/1010428317695951 |
| spellingShingle | Ajay Kumar Pritish Nilednu Azad Kumar Nilesh Kumar Sharma Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinoma Tumor Biology |
| title | Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinoma |
| title_full | Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinoma |
| title_fullStr | Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinoma |
| title_full_unstemmed | Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinoma |
| title_short | Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinoma |
| title_sort | epigenetic perturbation driving asleep telomerase reverse transcriptase possible therapeutic avenues in carcinoma |
| url | https://doi.org/10.1177/1010428317695951 |
| work_keys_str_mv | AT ajaykumar epigeneticperturbationdrivingasleeptelomerasereversetranscriptasepossibletherapeuticavenuesincarcinoma AT pritishnilednu epigeneticperturbationdrivingasleeptelomerasereversetranscriptasepossibletherapeuticavenuesincarcinoma AT azadkumar epigeneticperturbationdrivingasleeptelomerasereversetranscriptasepossibletherapeuticavenuesincarcinoma AT nileshkumarsharma epigeneticperturbationdrivingasleeptelomerasereversetranscriptasepossibletherapeuticavenuesincarcinoma |